Compare, Analyse SHASUN PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ADCOCK INGRAM
Jun-14
SHASUN PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs94386-   
Low Rs46279-   
Sales per share (Unadj.) Rs214.2114.9-  
Earnings per share (Unadj.) Rs5.3-29.0-  
Cash flow per share (Unadj.) Rs15.8-24.0-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.390.2-  
Shares outstanding (eoy) m56.62168.78-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.32.9 11.3%   
Avg P/E ratio x13.1-11.5 -114.1%  
P/CF ratio (eoy) x4.4-13.9 -31.9%  
Price / Book Value ratio x1.33.7 35.5%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,95856,135 7.1%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,1643,523 61.4%   
Avg. sales/employee Rs ThNM4,519.3-  
Avg. wages/employee Rs ThNM820.7-  
Avg. net profit/employee Rs ThNM-1,138.8-  
INCOME DATA
Net Sales Rs m12,12719,401 62.5%  
Other income Rs m229136 168.8%   
Total revenues Rs m12,35619,537 63.2%   
Gross profit Rs m1,009-3,362 -30.0%  
Depreciation Rs m594837 70.9%   
Interest Rs m415526 79.0%   
Profit before tax Rs m230-4,589 -5.0%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73287 -25.4%   
Profit after tax Rs m302-4,889 -6.2%  
Gross profit margin %8.3-17.3 -48.0%  
Effective tax rate %-31.7-6.2 506.7%   
Net profit margin %2.5-25.2 -9.9%  
BALANCE SHEET DATA
Current assets Rs m6,88414,210 48.4%   
Current liabilities Rs m8,4567,995 105.8%   
Net working cap to sales %-13.032.0 -40.5%  
Current ratio x0.81.8 45.8%  
Inventory Days Days62111 55.6%  
Debtors Days Days108124 86.8%  
Net fixed assets Rs m4,9708,283 60.0%   
Share capital Rs m11390 125.8%   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,02015,228 19.8%   
Long term debt Rs m1,8175,351 34.0%   
Total assets Rs m13,34728,767 46.4%  
Interest coverage x1.6-7.7 -20.1%   
Debt to equity ratio x0.60.4 171.2%  
Sales to assets ratio x0.90.7 134.7%   
Return on assets %5.4-15.2 -35.4%  
Return on equity %10.0-32.1 -31.2%  
Return on capital %13.3-19.8 -67.3%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m3981,656 24.0%  
From Investments Rs m-1,635-508 321.5%  
From Financial Activity Rs m1,3094,857 26.9%  
Net Cashflow Rs m716,004 1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.33 Rs / ZAR

Compare SHASUN PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SHASUN PHARMA With: PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  WOCKHARDT  FRESENIUS KABI ONCO.  IPCA LABS  



Today's Market

Sensex, Nifty Recover from Day's Low to End Marginally Higher; Divi's Lab & Tata Motors Top Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Related Views On News

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

Orchid Pharma Shares Zoom 7,700% in Seven Months. More Gains Ahead? (Views On News)

Jun 3, 2021

Here's why Orchid Pharma shares have rallied 7,700% in seven months.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

Don't Break These 5 Intraday Trading Rules (Fast Profits Daily)

Jun 1, 2021

To become a better intraday trader, follow these rules religiously.

The Most Visible Sign of India's Revival is on Two Wheels (Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Rs 2 Trillion Stimulus Coming to a Stock Market Near You (Profit Hunter)

Jun 2, 2021

Get ready to profit from a massive stimulus that you've never seen before.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SHASUN PHARMA

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

FEATURED VIDEOS

The 3-Word Secret to Earning Incredible Returns

Buy & Hold v/s In & Out Investing

An Investing System that Found 20 Winners in a Row

Top Pick for Next Decade

More Featured Videos

MARKET STATS